The 16th World ADC London takes place on 23–26 February 2026, bringing together over 800 senior decision-makers from biopharma, clinical research, service providers, investors, and regulators. As Europe’s largest forum dedicated to antibody–drug conjugates (ADCs), the summit offers a comprehensive programme covering discovery, translational science, clinical development, manufacturing, and regulatory strategy.
ADCs continue to transform oncology, delivering potent therapies directly to cancer cells while minimising off-target toxicity. As the field moves towards earlier-line treatments, developers face complex challenges, from payload optimisation and resistance mechanisms to scalable manufacturing. World ADC London 2026 addresses these challenges head-on, providing actionable insights from 110 global speakers across five content streams over four days of in-depth sessions, workshops, and panel discussions.
This year’s programme highlights next-generation payloads, bispecific constructs, dual-payload strategies, and non-antibody conjugates, giving attendees practical guidance on overcoming resistance, improving safety, and navigating evolving regulatory expectations. Strategic and commercial considerations are also central, with presentations from leading clinicians, regulatory experts, and investors sharing insights into clinical advancement, partnership opportunities, and emerging trends shaping the ADC landscape.
Networking remains a cornerstone of the event, with 14 hours of dedicated interaction built into the agenda. Structured networking sessions, one-to-one meetings, and informal discussions enable delegates to forge collaborations, explore licensing and investment opportunities, and exchange knowledge with peers from across the global ADC community.
Whether you are an early-career scientist, an experienced developer, or a strategic investor, World ADC London 2026 is the must-attend event for staying at the forefront of ADC innovation. From cutting-edge science to strategic insights and invaluable industry connections, the summit empowers participants to advance the next generation of ADCs from the lab to clinical and commercial success.
Contact: info@hansonwade.com | Event Guide | Registration & Pricing